Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation

Citation
Kt. Papazisis et al., Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation, CANCER LETT, 160(1), 2000, pp. 107-113
Citations number
22
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
160
Issue
1
Year of publication
2000
Pages
107 - 113
Database
ISI
SICI code
0304-3835(20001110)160:1<107:PTKIGE>2.0.ZU;2-Q
Abstract
Genistein, is a natural isoflavone compound with a potent activity against protein tyrosine kinases. The leukemic cell line, K562. is a bcr/abl (Phila delphia chromosome) positive cell line that is resistant to DNA-damaging ag ents, including gamma -irradiation. Treatment with genistein increased apop tosis and promoted G2-phase arrest in the non-apoptotic population of the y -irradiated K562 cells. Irradiated cells that survived 77- h after the irra diation had a normal distribution in cell cycle, whilst genistein treatment kept cells arrested in the G2-phase, decreased the S-phase fraction and su ppressed DNA-synthesis. Taken together, our results show that genistein aug ments apoptotic cell death after gamma -irradiation in K562 cells and this result cannot be attributed to abrogation of the G2/M checkpoint. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.